Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylaxis of endocarditis.

J T M van der Meer1

  • 1Department of Internal Medicine F4-217, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. j.t.vandermeer@amc.uva.nl

The Netherlands Journal of Medicine
|April 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.

The Journal of antimicrobial chemotherapy·2023
Same author

Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.

The Journal of antimicrobial chemotherapy·2023
Same author

Implementation of the 2015 European Society of Cardiology guidelines for the management of infective endocarditis in the Netherlands.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2020
Same author

[Antibiotic prophylaxis and endocarditis].

Nederlands tijdschrift voor tandheelkunde·2019
Same author

Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.

Journal of viral hepatitis·2016
Same author

Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control Study.

Open forum infectious diseases·2015

Antibiotic prophylaxis for endocarditis prevention following medical procedures is not highly effective. While it may slightly reduce an already low risk in patients with heart conditions, its overall efficacy remains limited.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Bacteraemia from medical/dental procedures can cause endocarditis in patients with heart disease.
  • Antibiotic prophylaxis was introduced in the 1940s to prevent procedure-related endocarditis.
  • Early expectations of prophylaxis efficacy were not met, despite animal studies showing prevention.

Purpose of the Study:

  • To discuss the theoretical background of endocarditis prophylaxis.
  • To explore potential reasons for the limited effectiveness of antibiotic prophylaxis.
  • To review the current understanding of endocarditis prevention strategies.

Main Methods:

  • Review of historical data and clinical observations.
  • Analysis of case-control studies on endocarditis prophylaxis.

Related Experiment Videos

  • Discussion of theoretical mechanisms and pharmacological principles.

    • Main Results:

    • Prophylaxis has not proven 100% effective in humans.
    • Recent case-control studies indicate limited effectiveness in reducing endocarditis incidence.
    • Prophylaxis may offer a marginal risk reduction for an already low-risk event.

    Conclusions:

    • Endocarditis prophylaxis demonstrates limited efficacy in preventing infective endocarditis in humans.
    • The benefits of prophylaxis are modest, reducing an already small risk.
    • Further research may be needed to understand and optimize preventive strategies.